首页> 外国专利> CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS

CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS

机译：暴露于放射性核素，生物制剂或化学制剂引起的疾病的Caspase抑制剂

页面导航

摘要
著录项
相似文献

摘要

The use of caspase inhibitors for treating cell death induced by radionuclides, biological agents, or chemical agents is disclosed. In particular, treatment of diseases or conditions caused by exposure to radionuclides, biological agents, or chemical agents, spread of radionuclides, biological agents, or chemical agents, explosion of radionuclides, biological agents, or chemical agents by terrorists or accidental exposure to radionuclides, biological agents, or chemical agents from a nuclear power plant, manufacturing or processing plant, research facility, or hospital is disclosed.

机译：公开了胱天蛋白酶抑制剂在治疗由放射性核素，生物试剂或化学试剂诱导的细胞死亡中的用途。特别是由于暴露于放射性核素，生物制剂或化学制剂，放射性核素，生物制剂或化学制剂的扩散，恐怖分子引起的放射性核素，生物制剂或化学制剂的爆炸或意外暴露于放射性核素引起的疾病或病症的治疗，公开了来自核电站，制造或加工厂，研究设施或医院的生物制剂或化学制剂。

著录项

公开/公告号EP1494700A2

专利类型
公开/公告日2005-01-12

原文格式PDF
申请/专利权人 CYTOVIA INC.;
展开▼

申请/专利号EP20030754361
发明设计人 CAI SUI XIONG;TSENG BEN Y.;
展开▼

申请日2003-04-07
分类号A61K38/00;A61K31/535;A61K31/44;A61K31/35;A61K31/27;A61K31/19;A61K31/195;
国家 EP
入库时间 2022-08-21 22:08:41

相似文献

专利
外文文献
中文文献